PETMED EXPRESS INC - Common Stock, $.001 Par Value (PETS) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, $.001 Par Value
Symbol
PETS on Nasdaq
Shares outstanding
21,007,296
Price per share
$3.22
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
6,982,895
Total reported value
$17,595,059
% of total 13F portfolios
0%
Share change
-389,734
Value change
-$1,201,818
Number of holders
59
Price from insider filings
$3.22
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PETMED EXPRESS INC - Common Stock, $.001 Par Value (PETS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Silvercape Investments Ltd 12% +11% $4,230,701 +$458,180 2,579,696 +12% SilverCape Investments Limited 09 Dec 2025
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 4.7% $3,048,942 974,103 Hotchkis and Wiley Capital Management, LLC 31 Dec 2024
VANGUARD GROUP INC 4.7% $3,017,483 964,052 The Vanguard Group 31 Dec 2024

As of 30 Sep 2025, 59 institutional investors reported holding 6,982,895 shares of PETMED EXPRESS INC - Common Stock, $.001 Par Value (PETS). This represents 33% of the company’s total 21,007,296 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of PETMED EXPRESS INC - Common Stock, $.001 Par Value (PETS) together control 32% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
RENAISSANCE TECHNOLOGIES LLC 6% 1,268,969 -0.38% 0% $3,185,112
VANGUARD GROUP INC 4.6% 964,052 0% 0% $2,419,770
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 3.8% 788,103 -4.7% 0.01% $1,978,139
BlackRock, Inc. 2.6% 542,735 -0.38% 0% $1,362,265
FEDERATED HERMES, INC. 2.3% 482,386 +0.2% 0% $1,210,788
DIMENSIONAL FUND ADVISORS LP 2.3% 481,517 +5.4% 0% $1,208,603
OAKTOP CAPITAL MANAGEMENT II, L.P. 2.1% 435,844 0% 0.1% $1,093,968
GEODE CAPITAL MANAGEMENT, LLC 0.97% 203,463 -7.1% 0% $510,843
CITADEL ADVISORS LLC 0.87% 181,879 +40% 0% $456,516
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.83% 175,233 -29% 0% $439,835
Man Group plc 0.72% 151,039 +7.1% 0% $379,108
PRICE T ROWE ASSOCIATES INC /MD/ 0.57% 120,055 0% 0% $302,000
Truffle Hound Capital, LLC 0.57% 120,035 0% 0.19% $301,288
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.51% 107,816 +164% 0.01% $270,618
AMERIPRISE FINANCIAL INC 0.5% 104,173 -27% 0% $261,474
Formidable Asset Management, LLC 0.47% 99,001 -14% 0.05% $328,683
STATE STREET CORP 0.46% 97,573 -1.7% 0% $244,908
UBS Group AG 0.41% 86,090 +11% 0% $216,086
NORTHERN TRUST CORP 0.29% 61,277 -11% 0% $153,805
Empowered Funds, LLC 0.29% 60,116 +201% 0% $150,891
AMERICAN CENTURY COMPANIES INC 0.29% 59,906 0% 0% $150,364
ROYAL BANK OF CANADA 0.19% 39,327 -54% 0% $99,000
Invesco Ltd. 0.17% 36,078 -51% 0% $90,556
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.17% 34,716 +112% 0% $87,138
CIBC Private Wealth Group LLC 0.14% 30,000 0% $75,300

Institutional Holders of PETMED EXPRESS INC - Common Stock, $.001 Par Value (PETS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 905 $2,896 -$5,622 $3.22 2
2025 Q3 6,982,895 $17,595,059 -$1,201,818 $2.51 59
2025 Q2 7,375,436 $24,585,642 -$1,852,842 $3.32 64
2025 Q1 7,853,232 $32,903,828 -$4,758,192 $4.19 71
2024 Q4 8,946,784 $43,121,057 -$1,874,126 $4.82 85
2024 Q3 9,432,758 $34,711,888 -$9,594,279 $3.68 92
2024 Q2 11,982,108 $48,530,078 -$10,451,760 $4.05 114
2024 Q1 14,543,626 $69,663,216 -$7,650,034 $4.79 111
2023 Q4 60,801 $459,656 +$330,243 $7.56 1
2023 Q3 13,257,880 $135,891,127 -$32,470,627 $10.25 135
2023 Q2 15,759,838 $217,534,938 -$24,268,171 $13.79 147
2023 Q1 17,288,424 $280,764,670 +$9,010,040 $16.24 161
2022 Q4 16,671,681 $295,115,797 +$3,878,466 $17.70 155
2022 Q3 16,381,630 $319,848,829 -$22,184,437 $19.52 157
2022 Q2 17,399,694 $341,970,793 +$6,988,913 $19.90 154
2022 Q1 17,061,198 $440,312,084 +$3,495,237 $25.80 164
2021 Q4 16,729,426 $422,691,078 +$9,022,443 $25.26 166
2021 Q3 16,644,453 $447,226,820 -$30,505,283 $26.87 179
2021 Q2 17,709,706 $563,616,710 +$37,291,883 $31.85 188
2021 Q1 16,386,288 $575,934,931 -$41,911,232 $35.17 198
2020 Q4 17,132,204 $549,079,458 -$10,373,480 $32.06 199
2020 Q3 18,229,765 $576,164,983 -$9,328,388 $31.62 194
2020 Q2 18,387,289 $655,076,552 +$63,081,084 $35.64 213
2020 Q1 16,826,435 $484,235,312 -$16,335,723 $28.78 192
2019 Q4 17,412,273 $410,094,461 -$8,697,392 $23.52 179
2019 Q3 17,891,400 $322,389,541 -$34,920,812 $18.02 157
2019 Q2 20,629,594 $323,199,104 -$47,768 $15.67 171
2019 Q1 19,870,967 $452,679,269 -$28,992,528 $22.78 190
2018 Q4 21,395,330 $497,608,905 +$27,197,835 $23.26 189
2018 Q3 19,508,242 $643,919,980 -$4,940,255 $33.01 188
2018 Q2 19,194,848 $845,359,194 -$21,134,902 $44.05 200
2018 Q1 19,781,006 $825,823,662 +$37,404,039 $41.75 199
2017 Q4 18,841,888 $857,212,154 -$67,069,381 $45.50 189
2017 Q3 20,418,329 $676,980,909 +$131,346,810 $33.15 174
2017 Q2 16,163,768 $656,357,611 +$49,538,371 $40.60 170
2017 Q1 15,325,736 $308,872,068 +$51,468,828 $20.14 147
2016 Q4 14,955,315 $345,079,268 +$4,185,411 $23.07 146
2016 Q3 15,111,591 $306,447,383 -$6,572,343 $20.28 148
2016 Q2 15,613,444 $293,016,607 -$18,958,947 $18.76 156
2016 Q1 16,438,115 $294,374,235 -$7,512,035 $17.91 152
2015 Q4 16,901,238 $289,747,561 -$12,666,900 $17.14 150
2015 Q3 16,839,176 $271,121,139 +$18,898,967 $16.10 146
2015 Q2 15,945,618 $275,177,518 +$23,046,223 $17.27 142
2015 Q1 14,434,310 $238,092,635 +$11,699,600 $16.52 134
2014 Q4 13,768,478 $198,018,063 +$7,494,664 $14.37 114
2014 Q3 13,219,820 $179,777,136 -$1,205,292 $13.60 120
2014 Q2 13,340,697 $179,823,971 -$7,007,541 $13.48 125
2014 Q1 13,807,153 $185,301,464 -$16,197,708 $13.41 128